Previous 10 |
Volatility watch: Some of the volatility names to watch include Nokia (NYSE: NOK ) , Kroger (NYSE: KR ) , Alexandria Real Estate (NYSE: ARE ) and Dave & Buster's Entertainment (NASDAQ: PLAY ) with short interest positions on the rise. Traders are also taking dead aim at retail n...
Gainers: Conduent (NASDAQ: CNDT ) +75% . More news on: Conduent Incorporated, OpGen, Inc., Groupon, Inc., Stocks on the move, , Read more ...
Alteryx AYX -21% on Q2 earnings . More news on: Volt Information Sciences, Inc., ADiTx Therapeutics, Inc., GEE Group, Inc., Stocks on the move, , Read more ...
Gainers: ADiTx Therapeutics (NASDAQ: ADTX ) +102% . More news on: ADiTx Therapeutics, Inc., American Virtual Cloud Technologies, Inc., NuZee, Inc., Stocks on the move, , Read more ...
Thinly traded nano cap ADiTx Therapeutics (NASDAQ: ADTX ) jumps 86% premarket on robust volume in reaction to its announcement that its AditxtScore test for COVID-19 has been validated in studies conducted at Stanford Blood Center in Palo Alto, CA. More news on: ADiTx Thera...
American Virtual Cloud Technologies (NASDAQ: AVCT ) +105% . on agreement to buy Ribbon's Kandy Communications business. More news on: American Virtual Cloud Technologies, Inc., ADiTx Therapeutics, Inc., Tivity Health, Inc., Stocks on the move, , Read more ...
Company Plans to file for an Emergency Use Authorization (EUA) and 510(k) Application in the Current Quarter (Q3, 2020) Loma Linda, CA, Aug. 06, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Aditxt Therapeutics, Inc. (Aditxt) (the “Company”) (Nasdaq: ADTX), a life sciences ...
LOMA LINDA, CA, Aug. 03, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – Aditx Therapeutics, Inc. (Aditxt) (the “Company”) (Nasdaq: ADTX), a life sciences company developing technologies specifically focused on improving the health of the immune system through immune monito...
News, Short Squeeze, Breakout and More Instantly...
ADiTx Therapeutics Inc. Company Name:
ADTX Stock Symbol:
NASDAQ Market:
ADiTx Therapeutics Inc. Website:
SAN DIEGO, July 25, 2024 (GLOBE NEWSWIRE) -- Women’s health innovator Evofem Biosciences, Inc. (“Evofem” or “the Company”) (OTCQB: EVFM) today announced that Saundra Pelletier, Chief Executive Officer and Amy Raskopf, Chief Business Development Officer...
Appili, with a commercial-stage pipeline, has raised CAD $100M towards developing therapeutics for the global infectious disease and biodefense markets. Subject to the renewal of certain legislation, two programs are potentially eligible for FDA Priority Review Vouchers Aditxt, Inc. (...
Evofem Biosciences Inc. (OTCQB: EVFM) , a company commercializing innovative products to address unmet needs in women's sexual and reproductive health, has signed a license and supply agreement for the Middle East rights to Phexxi(R), Evofem's FDA-approved, hormone-free contra...